Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesCTUnderstanding CT flow artifacts is key to better disease diagnosisUnderstanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.Molecular ImagingDual-tracer PET/CT shows promise in liver cancer patientsWomens ImagingStudies lacking for trans breast cancer screening trendsArtificial IntelligenceChatGPT performs poorly on ACR exam for residentsSponsor ContentIMV’s Oncology in Diagnostic Imaging Market Outlook Report